SENSEX
NIFTY
GOLD
USD/INR

Weather

image 17    C

Economy News

The Economic Times

Economy / The Economic Times

details

Wockhardt seeks 14-year data shield for India-made drugs

Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime + zidebactam), to treat complicated urinary tract infection, including acute pyelonephritis or severe kidney infections. Wockhardt has showcased six drugs to treat antimicrobial resistance (AMR).

4 Nov 2026 12:59 am